Backward Estimation of Exposure to Organochlorines using Repeated Measurements by Karmaus, Wilfried
Endosulfan’s Effects:
Omissions and Flawed Data
The main objective of the Endosulfan
Manufacturers and Formulators Welfare
Association in India is disseminating scien-
tific facts concerning the use of endosulfan.
Because endosulfan is used in several coun-
tries, the association watches for global news
and information relevant to endosulfan.
Members of the Endosulfan Manu-
facturers and Formulators Welfare Association
are of the strong opinion that Saiyed et al.
(2003) omitted significant information in
their published report “Effect of Endosulfan
on Male Reproductive Development.”
Consequently, to uninitiated readers the
article presented an alarming picture of endo-
sulfan, a pesticide registered for use in over
70 countries for more than 40 years.
Saiyed et al. (2003) failed to mention the
origin of their study. In fact, their study is an
integral part of an epidemiologic study sub-
mitted to the government of India in 2003,
“Report of the Investigation of Unusual
Illnesses Allegedly Produced by Endosulfan
Exposure in Padre Village of Kasargod
District” [National Institute of Occupational
Health (NIOH) 2003]. After studying this
report and other related studies, an expert
group appointed by the government of India
categorically concluded in February 2003
that “there is no link established between
use of endosulfan in PCK [Plantation
Corporation of Kerala] plantations and
health problems reported in Padre village”
(Central Insecticides Board and Registration
Committee 2003). The government of India
has since accepted this conclusion.
Epidemiology is a science of proving
association and not causation. Therefore, we
consider the conclusion of Saiyed et al.
(2003) that their “study results suggest that
endosulfan exposure may delay sexual matu-
rity and interfere with hormone synthesis in
male children” to be unscientific, uncalled
for, and objectionable. 
Saiyed et al. (2003) failed to mention the
fact that, besides endosulfan, a host of other
pesticides were also used in both exposed and
control study areas. The comment by EHP’s
Science Editor, Jim Burkhart, in the press
release dated 1 December 2003 (EHP 2003)
that “decades of spraying this pesticide
[endosulfan], and only this pesticide” is
therefore erroneous. 
The authors failed to mention the actual
quantity of endosulfan aerially applied in the
cashew plantation block closest to Vaninagar
school (exposed group), which was 105 g
active ingredient (ai)/acre/year. This rate
should be compared with the permissible sea-
sonal application rates elsewhere, including
the United States, where 1,000 g ai/acre/year
is often exceeded.
Saiyed et al. (2003) failed to take into
consideration the fact that the interval
between annual aerial applications was nearly
11 months and that the aerial applications
were made 5–6 months ahead of monsoon
rains. All this must be weighed against the
known half-life of endosulfan in conditions
in India (30–50 days).
In the proceedings of the expert group,
the experts on epidemiology and residue
science raised serious objections to the study
design, sample selection, and residue analysis
adopted by the NIOH (2003).
Endosulfan residue levels reported by
Saiyed et al. (2003) in blood samples are
1,000 times greater than the residue levels
reported in water samples by the authors in
the original report submitted in India
(NIOH 2003). The scientific properties of
endosulfan do not support this phenome-
non. Also, two studies by Kerala Agricultural
University (State of Kerala 2001) that pre-
ceded the article by Saiyed et al. (2003) did
not find endosulfan residues in water in
Padre village.
These are a few representative omissions
and flaws in the article by Saiyed et al.
(2003). Knowing the reputation and pro-
fessional excellence of EHP, I appreciate the
chance to address these problems here. 
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Endosulfan’s Effects:
Inaccurate Data
We would like to address problems with the
article “Effect of Endosulfan on Male
Reproductive Development” by Saiyed et al.
(2003). Our comments are based on exten-
sive discussions with several experts and
decision-making bodies on the subject.
First, Saiyed et al. (2003) described the
results from a report first submitted in India
in July 2002 by the National Institute of
Occupational Health (NIOH 2002). We
noted with interest that Saiyed et al. (2003)
did not include additional or new data in the
article beyond what was presented in the
original report (NIOH 2002). Consequently,
there was no need for discussing the results
again.
The original NIOH report (NIOH 2002)
was submitted to an expert panel of Indian
scientists appointed by the Government of
India. The results of this review were reported
to the Indian Central Insecticides Board and
Registration Committee in April 2003. The
committee was highly critical of the overall
conduct of the study and concluded that
“there is no link established between use of
endosulfan in PCK [Plantation Corporation
of Kerala] plantations and health problems
reported in Padre village”(Central Insecticides
Board and Registration Committee 2003).
This was further endorsed at a subsequent
meeting of the Registration Committee in
September 2003. The Indian scientists who
reviewed this report evidently had some
major advantages of additional information
that were not available to the reviewers of
the article by Saiyed et al. (2003). Namely,
they had access to all of the data, they could
consult the authors, and they clearly com-
prehended the local situation in the region
of India under consideration. Therefore,
they found that the NIOH study (NIOH
2002) failed to prove what appeared to be
an apparently flawed hypothesis.
Referring to the statement by the
Central Insecticides Board and Registration
Committee (2003), the Minister for
Agriculture reiterated in the Indian parlia-
ment that “The [Government] of India also
constituted an expert committee and based
on its recommendations decided that the
use of endosulfan be continued as per provi-
sions of Insecticides Act 1968 as there is no
link established between the use of endosul-
fan in PCK plantations and health problems
in Padre village.” 
In their article in EHP, Saiyed et al.
(2003) emphasized the premise that the geo-
graphical area studied was unique, with only
a single pesticide used over a long period of
time. Unfortunately, this is not correct; local
records show that several pesticides were
applied in this area. Furthermore, what is
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eral of the same pesticides were also com-
monly used in the control area. Thus, the
scientific value of this study is questionable.
For sexual maturity rating (SMR) and
hormone levels, the results presented by
Saiyed et al. (2003) displayed a relatively
poor correlation with age; this is not enough
to clearly describe a positive correlation.
There are two additional confounding fac-
tors: a) small sample size (small number of
subjects and only one blood sample per sub-
ject), which was recognized by the authors,
and b) Saiyed et al. (2003) did not mention
the normal biological ranges for either SMR
or hormone levels in such a population. For
example, serum hormone levels are highly
variable and, without reference to what
would be considered a normal range, the
authors cannot confidently claim that the
apparent changes they described were caused
by pesticide exposure. This is evident in the
last paragraph of the article, in which Saiyed
et al. (2003) concluded that “ long-term fol-
low-up of the children is essential to under-
stand the implications.” As a measure of
endosulfan exposure, the authors described
serum levels of endosulfan and endosulfan
sulphate. There are a number of interesting
paradoxes with these results. The first is that
endosulfan was not used in the area, as
described in the article, for 10 months
before the study started. Given the rapid
biodegradation and subsequent clearance of
endosulfan in this type of environment, it is
surprising that endosulfan was discovered in
these samples. To further confound this, the
levels of endosulfan, again as described by
Saiyed et al. (2003), were ≥ 0.03 ppb in
water and ≥ 0.3 ppb in pond sediments,
well below the levels in the serum samples.
Endosulfan is rapidly cleared from the body
and does not bioaccumulate; thus, the
serum levels are clearly at odds with those
found in water samples, including those of
the control samples. It should also be added
that the water levels of endosulfan described
by Saiyed et al. (2003) are well below the
maximum recommended by the U.S.
Environmental Protection Agency (EPA).
The distance between PCK plantations
and Vaninagar school is about 3 km. The
amount of endosulfan applied in the PCK
plantation block closest to Vaninagar
school was about 105 g active ingredient
(ai)/acre/year, whereas the permissible appli-
cation rates authorized by the U.S. EPA are
> 1,000 g ai/acre/season. Saiyed et al. (2003)
did not include this fact in their article.
In the area described by Saiyed et al.
(2003), aerial application was carried out by
helicopter at a height of about 10 feet above
cashew tree plantations. It is highly unlikely
that the sprayed endosulfan would drift
away all the way to the Vaninagar school
area 3 km away. Also, the interval between
annual aerial applications was about
11 months. Endosulfan is likely to undergo
significant degradation during this period.
In this area, it is highly unlikely that sig-
nificant amounts of endosulfan would have
translocated with rainwater runoff during
monsoon rains, which normally occur
5–6 months after aerial application. Under
typical conditions in India, significant degra-
dation of endosulfan would have occurred.
The endosulfan residue levels Saiyed
et al. (2003) reported in blood samples were
1,000 times higher than those reported in
water samples. Based on the physicochemical
properties of endosulfan, such a finding is
highly unlikely.
Finally, the reproductive effects of endo-
sulfan reported by Saiyed et al. (2003) are
inconclusive.
We are concerned with the comment
made by EHP’s Science Editor, Jim Burkhart,
in the press release dated 1 December 2003
(EHP 2003): 
Decades of spraying this pesticide, and only this
pesticide, on the village provided a unique oppor-
tunity to analyze its impact. Although the sample
size is somewhat limited, the results are quite
compelling.
Calling the results “compelling” has caused
significant paranoia among users of endosul-
fan and the general public. A number of pes-
ticides were in use around Padre village for
many decades, so it was not correct to state
that only one pesticide was used.
In conclusion, we hope we have shown
that the article by Saiyed et al. (2003) does
not contribute to the knowledge on the
behavior of endosulfan or to the research to
determine the cause of health problems of
the people in Padre village. 
In view of the foregoing facts, we believe
that EHP should reevaluate their review of
the article by Saiyed et al. (2003).
The author is employed by CropLife India, an
organization that represents the plant science
industry.
A. S. Indulkar 
CropLife India
Mumbai, India
E-mail: croplifeind@vsnl.net
REFERENCES
Central Insecticides Board and Registration Committee. 2003.
Minutes of the 233rd Meeting of the Registration
Committee. Available: http://www.cibrc.nic.in/rc.htm
[accessed 26 May 2004].
EHP. 2003. Young Males Exposed to Pesticide Endosulfan See
Delay in Sexual Maturation. Research Triangle Park,
NC:Environmental Health Perspectives, National Institute of
Environmental Health Sciences. Available: http://ehp.niehs.
nih.gov/press/120103.html [accessed 6 January 2004].
NIOH. 2002. Investigation of Unusual Illnesses Allegedly
Produced by Endosulfan Exposure in Padre Village of
Kasargod District (N. Kerala). Ahmedabad, India:National
Institute of Occupational Health.
Saiyed H, Dewan A, Bhatnagar V, Shenoy U, Shenoy R,
Rajmohan H, et al. 2003. Effect of endosulfan on male
reproductive development. Environ Health Perspect
111:1958–1962.
Endosulfan’s Effects: Saiyed’s
Response
I would like to respond to the comments of
both Abraham and Indulkar about the origin
and results of our study (Saiyed et al. 2003). 
On the basis of media reports of unusual
illnesses in Padre village, we were asked by
the National Human Rights Commission to
investigate these illnesses and determine if
they were linked to endosulfan exposure.
These reported illnesses consisted of birth
defects, growth- and development-related
problems in children, neurologic disorders,
epilepsy, allergic disorders, cancers, and high
rates of suicide. On the basis of our site visit,
study of the topography of the area, the
report of the Regional Remote Sensing
Service Centre (Nageswara Rao PP, personal
communication), and information from the
Plantation Corporation of Kerala (PCK), we
determined that we had a unique opportu-
nity to study various health effects of long-
term exposure to endosulfan on human
health.
Our study (Saiyed et al. 2003) had two
components: a) an investigation of growth-
and development-related parameters, such
as physical growth (height and weight),
skin-fold thickness, IQ, study of behavioral
problems and scholastic performance, sex-
ual maturity rating (SMR), and an estima-
tion of sex hormones, in schoolchildren
exposed to the aerial spray of endosulfan;
and b) an investigation of diseases, such as
neurologic and psychiatric disorders, infer-
tility, and allergic disorders, in the adult
population, which was carried out through
secondary data collection from parents of
the children.
In our report submitted to the National
Human Rights Commission, [National
Institute of Occupational Health (NIOH)
2002], we reported a higher prevalence of
birth defects in both male and female chil-
dren, lower mean SMR and serum testos-
terone levels in male children of similar age,
a higher prevalence of scholastic backward-
ness, and neurobehavioral problems in chil-
dren who had been exposed to endosulfan
through aerial treatment of fields (NIOH
2002). We suggested a possible link between
endosulfan exposure and these problems,
which has been reported in a number of pub-
lished animal experimental studies, for exam-
ple, endosulfan-related birth defects (Food
Machinery and Chemical Corporation 1980;
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García-Rodríguez et al. 1996; Gupta et al.
1978]; scholastic development (Lakshmana
and Raju 1994; Paul et al. 1994); and repro-
ductive effects in males (Dalsenter et al.
1999; Sinha et al. 1997, 2001). We submit-
ted our report to the Registration Committee
at their request. The eight-member expert
committee, which included two major
stakeholders of endosulfan in the country,
was set up by the Registration Committee to
examine our report along with the report of
the Kerala Agriculture University (KAU) and
the Fredrick Institute of Plant Protection and
Toxicology (FIPPAT). The committee raised
issues, many of which are also mentioned in
the letters from Abraham and Indulkar, and
remarked that “the findings of the NIOH
study are not in conformity with the known
and accepted properties, chemistry and toxi-
cology of endosulfan” (Dubey 2003). The
committee concluded that the study did not
establish a link between endosulfan exposure
and the health problems in Padre village.
The decision of the committee was not
unanimous.
One of the important components of
any scientific investigation is dissemination
of information to other scientists through
publication of the results in a suitable jour-
nal; therefore, we submitted a manuscript
covering part of the study to EHP. The
opinion of the expert committee and their
deliberations in no way affected our right of
scientific communication. Our study was
scientifically planned, designed, and carried
out by a team of experts, which included
epidemiologists, physicians, pediatricians,
medical toxicologists, statisticians, analytical
chemists, and biochemists, who have years
of experience in conducting such studies
and have many publications to their credit.
Our article (Saiyed et al. 2003) was based
on a portion of the results of the study in
children. Some of the other parameters
related to growth and development will be
communicated at a later date.
Both Abraham and Indulkar comment
that several pesticides were used in the area,
so endosulfan cannot be blamed for the
reported health problems. Based on the
topographic study of the area, we were con-
cerned about what was sprayed on the
cashew plantation, which covered a very
large area on the hills; we believed that com-
pounds sprayed on the plantation would run
off into streams used by residents of the vil-
lage downhill from the plantation. We asked
the PCK, the owners of the cashew planta-
tion, to give us information on all pesticides
that were sprayed in the study area. On
20 August 2001, PCK informed us that
since 1980 they had aerially sprayed endo-
sulfan (0.1% of 35% emulsifiable concen-
trate) twice a year almost every year. They
did not mention the use of any other pesti-
cides. In their letters, Abraham and Indulkar
mention the use of other pesticides in the
area; this probably refers to the valley where
there are small farms that are owned by the
local families. The major crop in this valley
and in the control area is areca nut, for
which Bordeaux mixture (copper sulfate and
lime) is used. The small family farms in the
valley and in the control village had a similar
crop pattern; therefore, we can assume local-
ized ground use of pesticides. This type of
localized pesticide use is unlikely to cause
significant widespread exposure. Our con-
clusions (Saiyed et al. 2003) were based on
the comparison of the control and study
areas on the basis of aerial exposure; there-
fore, the use of other pesticides, if similar in
both the study and control areas, would not
affect our conclusions. The issue of finding
endosulfan in serum samples of the control
population was adequately addressed in the
“Discussion” of our article (Saiyed et al.
2003). 
In their letters, Abraham and Indulkar
comment that downward movement of the
pesticides could start only at the onset of
monsoons 5–6 months after exposure, by
which time no endosulfan would remain
because it biodegrades rapidly. The NIOH
and three other agencies carried out endo-
sulfan analyses at varying times (January
2001–August 2001) and reported significant
amounts of endosulfan in various environ-
mental media. First, the Centre for Science
and Environment, New Delhi (a nongovern-
ment organization), analyzed biological and
environmental samples for endosulfan
residues in January 2001, 1 month after the
last aerial spray of endosulfan carried out on
26 December 2000. The results showed that
the concentration of endosulfan in three
water samples was 7–51 times higher than
the maximum residue limit (MRL) (Joshi
2001). Very high levels of endosulfan were
reported in samples of human blood,
human milk, vegetables, spices, cow’s milk,
animal tissues, cashews, cashew leaves, and
soil. In one of the soil samples, the concen-
tration of endosulfan was 391 times higher
than the MRL.
Second, the KAU, Thrissur District
(Kerala), India, studied endosulfan levels in
soil (n = 4), plants (n = 5), water (n = 5), and
sediment (n = 1) in the pond in the valley on
19 February 2001 using an HPLC–
spectrophotometric detector technique.
They reported endosulfan in soil (3,815 ppb
on PCK plantation), 55 ppb in the mid-hills,
and 315 ppb in the sediment in the pond
(Mathew S, personal communication). They
also reported 507–858 ppb endosulfan in
cashew leaves. Their report clearly demon-
strated downward movement of endosulfan
from hills to the pond water (Figure 1).
(Mathew S, personal communication).
Third, FIPPAT, Padappai, India, carried
out sampling between March and May
2001 in cashew leaves (n = 28), human
blood (n = 112), water (n = 30), and soil
(FIPPAT 2001). The authors reported up to
3,430 ppb endosulfan in cashew leaves,
1–11 ppb in soil, and no endosulfan in
blood or water samples. On examination of
the report (FIPPAT 2001), we noted large
peaks of alpha- and beta-endosulfan in some
chromatographs of soil, leaf, and blood sam-
ples that they had not mentioned. We
reported this discrepancy to the expert com-
mittee and requested action. 
The results of the studies by the Centre
for Science and Environment in January
2001 (Joshi 2001), the KAU in February
2001 (Mathew S, personal communication),
and FIPPAT (2001) in March–May 2001
clearly indicate significant translocation of
endosulfan from the hills to the valley and
its persistent nature.
Abraham and Indulkar both noted a dis-
crepancy in our article (Saiyed et al. 2003)
between endosulfan levels in serum and
water. They both assume that the endosul-
fan exposure occurred only through water,
which is not correct. Endosulfan adhers to
the soil particles; runoff water then carries
the endosulfan attached to soil particles from
leaf surfaces and the ground during the first
few rainfalls. Also, winter rains are common
in this area of India. This view is largely
supported by the KAU study (Mathew S,
personal communication), which showed
high levels of endosulfan (315 ppb) in pond
sediment in the study village. Endosulfan
attached to soil particles can enter the body
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Figure 1. Altitude-wise distribution of endosulfan.
ND, not detected. Reproduced with permission
from Samuel Mathew, Department of Chemistry,
Kerala Agriculture University.
Altitude-wise distribution of
endosulfan residues
PCK plantation
(hilltop)
Soil : 0.9–3.8 ppm
Water : ND
Plants : 0.5–0.9 ppm
Resident’s premises
(mid–hill)
Soil : 0.055 ppm
Suranga water : ND
Plants : ND
Resident’s premises
(valley)
Rivulet water : ND
Open pond water : ND
Sediment : 0.315 ppmCorrespondence
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through the dermal route, more so in a hot
and humid climate (excessive sweating),
and through ingestion, particularly in chil-
dren, who commonly have hand-to-mouth
behavior. Endosulfan attached to the soil
particles can also be translocated through
other environmental media.
Indulkar raised several points about the
results of our article (Saiyed et al. 2003). He
incorrectly stated that we found poor correla-
tion of SMR and hormone levels with age;
our correlations are shown in Tables 2 and 3
of our article (Saiyed et al. 2003). He also
complained that we had not compared the
ranges of SMR and hormone levels in our
study groups to normal ranges, but we did
not consider it necessary because we were
comparing the groups with each other. Also,
Indulkar’s points about the wide variability
of hormone levels and small sample size were
discussed and clarified in our article.
Both Abraham and Indulkar stated that
endosulfan cannot travel a distance of
3–4 km and that it biodegrades quickly.
The long half-life of endosulfan in soil is
well known and was mentioned in our
“Discussion” (Saiyed et al. 2003). The U.S.
Environmental Protection Agency (EPA
2002) reported that 
Endosulfan is a volatile and persistent cyclodiene
pesticide that can migrate over a long distance
through various environmental media such as air,
water and sediment. Once endosulfan is applied
to crops, it can either persist in soil as a sorbed
phase or be removed through several physical,
chemical and biological processes. Recent studies
suggest that secondary emissions of residual
endosulfan continue to recycle in the global sys-
tem while they slowly migrated and are rede-
posited via wet deposition in the Northern
Hemisphere. The occurrence of endosulfan in
remote regions like the Great Lakes, the Arctic
and the mountainous areas is well documented.
Endosulfan can also enter the air as adsorbed
phase onto suspended particulate matter, but this
process does not appear to be a major contributor
to long range transport like volatilization.
The information provided above further
supports the comment made by Jim
Burkhart, EHP Science Editor, that 
Decades of spraying this pesticide, and only this
pesticide, on the village provided a unique oppor-
tunity to analyze its impact. Although the sample
size was somewhat limited, the results are quite
compelling. 
We stand by the conclusions in our article
(Saiyed et al. 2003).
The author declares he has no competing
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Defining Wetlands
I read with interest David J. Tenenbaum’s
article about constructed wetlands in the
January 2004 issue of EHP (Tenenbaum
2004). While I noted his caveat that “their
design remains a bit of an uncertain art,” I
think he should have gone further to ensure
that engineers do not immediately embrace
constructed wetlands as a panacea for waste
treatment and decontamination.
I also find myself increasingly unsettled
by articles such as this one as potentially and
inadvertently capitalizing on the opinion of
the populace that wetlands are good places—
a widespread view these days (deservedly so)
because of excellent advocacy by government
agencies and environmental nongovernment
organizations such as Ducks Unlimited.
Although the sewage treatment facilities
promoted in the article  (Tenenbaum 2004)
may resemble wetlands, they are far from the
real thing, or at least as far as the term is gen-
erally understood. In fact, I noted that later
in the article Tenenbaum turned his atten-
tion to wetland restoration projects. In my
experience, these again generally involve real
wetlands, so to speak. Thus our wetland con-
trivances, enhancements, or other more utili-
tarian versions are more fairly not referred to
as “restoration” for the straightforward rea-
son that the former condition of these sites,
the target for restoration, did not include
sewage treatment.
The waste treatment benefits from con-
structed wetlands are clear, and Tenenbaum
(2004) is to be commended for pointing this
out as well as the uncertain risks. We cross
the line, however, when we pitch con-
structed wetlands without mentioning the
caveat that these surrogate ecologic features
are intended to become contaminated (per
heavy metal sinks, for example) and that this
will impair other uses for these facilities,
including use as habitat for species that rely
on wetlands and cannot discern the real
from the fake. Nature’s way advises us to be
responsible about our waste generation at
the source and not to dress up the end-of-
pipe solution.
The author declares he has no competing
financial interests.
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Phthalate Exposure and Early
Thelarche
Several years ago Colón et al. (2000) reported
higher levels of phthalates, particularly di-(2-
ethylhexyl) phthalate (DEHP) in serum from
41 girls experiencing premature breast devel-
opment (thelarche) as compared to 35 age-
matched controls. These data seem puzzling
for at least two reasons. First, in light of the
pharmacokinetic properties of phthalates, the
reported blood levels are very high when com-
pared to more recent exposure information,
and, second, toxicologic evidence shows that
phthalates do not act like estrogens under
in vivo conditions, nor do they affect female
sexual development and maturation in
rodents. Despite these concerns, the study by
Colón et al. (2000) is one of the few studies
that has compared chemical exposures with
sexual development and, as a consequence, it
is now being cited by authors developingCorrespondence
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hypotheses for future research programs on
children’s health (e.g., Chapin et al. 2003).
There have been a number of recent scientific
developments that relate to these matters.
Thus, it seemed timely to summarize the
exposure and toxicologic information that
would be relevant in assessing whether low-
level exposure to phthalates, which might be
experienced under typical ambient condi-
tions, could influence human female sexual
development.
Colón et al. (2000) reported an average
DEHP concentration of 450 ppb (nano-
grams per milliliter) DEHP and 3 ppb
monoethylhexyl phthalate (MEHP, the first
metabolite of DEHP) in serum samples from
the referred cases. In comparison, they found
70 ppb DEHP in controls, whereas MEHP
was below levels of detection. In general, the
measurement of phthalates in biological flu-
ids and other media can be quite problematic
because of the potential for laboratory
contamination due to the use of flexible vinyl
in laboratory equipment and tubing. Also,
the use of flexible vinyl in liners for reagent
bottles is common (e.g., Kessler et al. 2001).
Much of the historical data on phthalate lev-
els is questionable, and investigators are now
measuring phthalate metabolites in biological
media as a way of avoiding the sample con-
tamination problems (e.g., Blount et al.
2000a, 2000b; Kessler et al. 2001). However,
taking the data at face value, the results are
difficult to rationalize with information on
phthalate pharmacokinetics and exposure. 
Within the population at large, the prin-
cipal route of exposure to phthalates is via
food (e.g., Clark et al. 2003). Ingested
phthalates are converted to the correspond-
ing monoesters before absorption (e.g.,
Kluwe 1982), and blood levels of phthalate
diesters are normally very low. To put this
into perspective, a blood level of 450 ppb
DEHP is approximately 1.2 µM. In a recent
pharmacokinetic study of DEHP in the mar-
moset (Kessler et al. 2004), oral doses of
DEHP at levels of 30 and 500 mg/kg
resulted in peak blood levels of DEHP of
0.3 and 1.8 µM. Using a linear allometric
extrapolation, an oral dose of approximately
300 mg/kg DEHP would be required to pro-
duce a blood level of 450 ppb. In contrast,
the average DEHP exposure among U.S.
children at ages similar to those examined by
Colón et al. (2000) is 2.6 µg/kg/day (McKee
et al. 2004; calculated from urinary metabo-
lite data of Brock et al. 2003). Thus, the
blood concentration data reported by Colón
et al. (2000) are very unusual, and, if correct,
imply extraordinary exposures by comparison
to those of other children of similar ages.
Further, as indicated above, DEHP is
rapidly metabolized to its corresponding
monoester, MEHP [mono-(2-ethylhexyl)
phthalate]. In a pharmacokinetic study in
marmosets (Kessler et al. 2004), oral doses of
30 and 500 mg/kg resulted in peak MEHP
concentrations of 8 and 66 µM, approxi-
mately 20 times greater than the peak
DEHP levels at equivalent doses. In contrast,
the average MEHP level of 3 ppb reported
by Colón et al. (2000) was more than two
orders of magnitude below the reported aver-
age DEHP level. The only imaginable situa-
tion that might produce such anomalous
results is if the blood samples had been taken
immediately after direct introduction of
DEHP into the blood stream. This is theo-
retically possible, but the reported levels still
seem unlikely. The only way in which signif-
icant levels of unmetabolized phthalates may
enter the blood stream is by way of medical
devices including blood bags, tubing, and
other medical equipment [e.g., Food and
Drug Administration (FDA) 2001]. DEHP
is the primary phthalate plasticizer for such
vinyl medical devices. However, as shown
in an assessment by the FDA (2001), only
critical-care procedures could produce blood
levels that begin to approach the levels
reported by Colón et al (2000). Further, in
blood, DEHP is rapidly metabolized with a
biological half-life in humans of < 6 hr (e.g.,
Peck and Albro 1982). Thus, assuming
medical treatment to be the explanation for
the high DEHP/MEHP ratio reported by
Colón et al. (2000), the measured blood
levels imply intensive care procedures per-
formed in the few hours proceeding the
blood collection. However, given the cir-
cumstances this seems unlikely.
In the study by Colón et al. (2000), the
blood samples were taken from children
after referral to pediatric clinics, that is,
after premature thelarche had been
observed. Because phthalates are rapidly
metabolized and excreted, the blood level
data, if not the result of laboratory contami-
nation, could only have reflected exposures
occurring shortly before the blood was
drawn. For the hypothesized link between
phthalate exposure and early breast develop-
ment to be supported, one would have to
assume that these point estimates were
indicative of a pattern of exposure that had
persisted for an extended period of time.
But, as shown above, the conditions leading
to the reported blood levels are so unusual
that they cannot reflect an extended expo-
sure profile. Analytical difficulties seem a
more likely explanation to reconcile the
data reported by Colón et al. (2000) with
the extensive body of information on
phthalate pharmacokinetics.
The second general reason why an asso-
ciation between phthalate exposure and the
early onset of puberty in girls is puzzling and
seems unlikely is that it is not supported by
the toxicologic data. There is a hypothesis
that premature thelarche is a consequence
of unintentional exposure to estrogen or
estrogen-like substances (e.g., Li et al. 2002;
Tiwary 1998). It has been reported that
some phthalates, although not DEHP, can
bind and activate the estrogen receptor
under in vitro conditions (e.g., Jobling et al.
1995; Soto et al. 1995); however, subse-
quent work has shown that this is an arti-
fact of the testing conditions. 
As described above, under in vivo condi-
tions the phthalates are rapidly metabolized
to the corresponding monoesters, but these
metabolites are not active under in vitro
conditions (Brady et al. 1998; Harris et al.
1997; Picard et al. 2001). In rats and mice,
phthalates are inactive in uterotrophic assays
and do not induce vaginal cornification
(Kanno et al. 2003; Zacharewski et al.
1998). Similarly, in longer-term studies
phthalates do not influence age at vaginal
patency or estrous cyclicity and do not oth-
erwise influence sexual development or
behavior in female rats (Moore 2000). Some
phthalates produce effects in male rats,
apparently as a result of alterations in testos-
terone synthesis (Parks et al. 2000), but
these alterations do not produce estrogen-
like effects in female rats (Gray et al. 1999;
Moore et al. 2001; Mylchreest et al. 1998,
1999). With respect to female reproductive
development, the only effect that has been
described in rats relates to histologic changes
in the ovary that occur at very high doses
(Lovekamp-Swan and Davis, 2003;
Lovekamp-Swan et al. 2003). 
These changes seem to be caused by inhi-
bition of aromatase activity in the granulosa
cells. Aromatase inhibition reduces conver-
sion of testosterone to estradiol and produces
what is effectively an antiestrogenic effect
under these circumstances. However, this
seems unlikely to have any public health
implications, partly because the doses
required in rodents are much higher than
those to which humans are exposed and also
because the aromatase inhibition is depen-
dent on activation of the peroxisome prolifer-
ator-activated receptor α (PPARα). In other
situations, there is evidence that PPARα-
dependent effects exhibit profound species
specificity, with rodents being very sensitive
and humans being much less sensitive, if not
refractory (e.g., Klaunig et al. 2003).
In summary, the purported relationship
between phthalate exposure and early the-
larche (Colón et al. 2000) seems highly
unlikely, in part because the reported expo-
sure levels do not seem plausible given other
information on phthalate exposure, and
also because phthalates do not influence
the timing of female sexual development in
laboratory studies.Correspondence
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Editor’s Note: In accordance with journal
policy, we attempted to contact Osvaldo Rosario,
the corresponding author, to ask whether he
wanted to respond to this letter, but our
attempts have not been successful.
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Correction
Karmaus et al. detected errors in their article “Backward Estimation of Exposure to
Organochlorines using Repeated Measurements” [Environ Health Perspect 112:710–716
(2004)]. In Table 1, values in the equations for the proposed regression model were incorrect.
The correct equations for Table 1 are as follows:
For estimation of 1970s values from 1980s values,
PCB_70(estimate) = PCB_80 * 0.565 + (ϕ_80 * –0.163) + (ω * 0.106)
For estimation of 1980s values from 1990s values
PCB_80(estimate) = 10[–0.193 + (log10 PCB_90 * 0.781) + (ϕ_90 * 0.049) + (η_90 * –0.145)]
Also, in Figure 3, there should not be a measurement for the year 2010.
The authors appologize for the errors.